MLMin Li

Min Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Min Li has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Daxiong Zeng

    Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China

    1 shared publication
  • Gengyun Sun

    Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China

    1 shared publication
  • Junsheng Zhou

    Hefei Prevention and Treatment Center for Occupational Diseases, Hefei, Anhui 230022, P.R. China

    1 shared publication
  • Lan Xiao

    Department of Gynecology The Third Affiliated Hospital of Sun Yat‐sen University Yuedong Hospital Meizhou Guangdong China

    1 shared publication
  • Min-Min Zhang

    Department of Obstetrics & Gynecology, the First Affiliated Hospital, Anhui Medical University, Hefei, China

    1 shared publication
  • Ran Wang

    Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People’s Republic of China

    1 shared publication

Latest Publications

  • Open Access

    Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway

    by Lan Xiao, Xiao-Yan Shi, Ze-Lian Li, Min Li, Min-Min Zhang, Shi-Jie Yan, Zhao-Lian Wei

    Xiao L, et al. J Gynecol Oncol. 2021 Jun;32(5):e77. https://doi.org/10.3802/jgo.2021.32.e77


  • Open Access

    Effects of basic fibroblast growth factor and cyclin D1 on cigarette smoke-induced pulmonary vascular remodeling in rats

    by Sijing Zhou, Min Li, Daxiong Zeng, Gengyun Sun, Junsheng Zhou, Ran Wang

    Cigarette smoking may contribute to pulmonary hypertension in chronic obstructive pulmonary disease by resulting in pulmonary vascular remodeling that involves pulmonary artery smooth muscle cell proliferation. This study investigated the effects of basic fibroblast growth factor (bFGF) and cyclin D1 on the pulmonary vascular remodeling in smoking‑exposed rats. Twenty‑four male Wistar rats were randomly divided into four groups. Three tobacco-exposed groups were exposed to the smoke produced by 20 cigarettes for 60 min, twice a day for two, four or eight weeks, and the control group were exposed to fresh air. The expression of bFGF and cyclin D1 in the pulmonary arterial smooth muscle cells were determined using immunohistochemistry. Quantitative polymerase chain reaction was conducted to determine the expression levels of bFGF and cyclin D1 mRNA. In addition, the expression of bFGF and cyclin D1 proteins was evaluated by western blotting. The expression of bFGF and cyclin D1 at the mRNA and protein levels was shown to increase with the duration of smoke exposure (P<0.05). The correlation analysis indicated the expression of bFGF and cyclin D1 was positively associated with the pulmonary vessel wall thickness. The expression of bFGF was positively associated with that of cyclin D1. Collectively, the data demonstrated that the upregulation of bFGF and cyclin D1 occurred in rats subjected to smoke exposure, which may be associated with the abnormal proliferation of the smooth muscle cells in the pulmonary arteries.